Bernard Hublot, Compiegne FR
Bernard Hublot, Compiegne FR
Patent application number | Description | Published |
---|---|---|
20090187034 | PROCESS FOR THE PREPARATION OF STIRIPENTOL PARTICLES HAVING A DEFINED PARTICLE SIZE DISTRIBUTION - The invention relates to a process for the preparation of stiripentol particles having a defined particle size distribution. | 07-23-2009 |
20090298817 | ANTI-AMNESIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM - The present invention relates to the use of at least one compound of formula (I) as follows: | 12-03-2009 |
20100144863 | COMPOUNDS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDERS - The present invention relates to a compound of the following formula (I): | 06-10-2010 |
20100197777 | Synergistic combination of analgesic compounds - The present invention relates to a pharmaceutical composition comprising as active substances: | 08-05-2010 |
20100240588 | COMPOUND FOR USE IN THE TREATMENT OF PERIPHERAL NEUROPATHIES - The present invention relates to a compound of the following formula (I): | 09-23-2010 |
20110135616 | Medicinal Product for Treating Gastrointestinal Ulcers - The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers. | 06-09-2011 |
20110136885 | Synergistic Combination of Analgesic Compounds - The present invention relates to a pharmaceutical composition comprising as active substances: | 06-09-2011 |
20130079336 | Treatment of Prolonged Status Epilepticus - Methods for terminating, preventing, and/or treating status epilepticus are generally provided. The method can include administering a prophylactically or therapeutically effective amount of stiripentol or a related compound thereof to an individual in need of treatment of status epilepticus. The individual can be in need of treatment of prolonged status epilepticus, refractory status epilepticus, and/or benzodiazepine-resistant status epilepticus. | 03-28-2013 |